Lupvindol Biosciences is a biotechnology company that treats autoimmune and inflammatory conditions affecting both humans and animals.
Lupvindol Biosciences has raised $2.2M in total funding. The most recent round was Seed. The last funding was announced in December 2024.
Lupvindol Biosciences is headquartered in Oceanside, United States.
Lupvindol Biosciences is a biotechnology company that treats autoimmune and inflammatory conditions affecting both humans and animals.
Lupvindol Biosciences is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Lupvindol Biosciences — Funding & Investors." VCBacked, December 23, 2024, https://www.vcbacked.co/company/lupvindol-biosciences. Accessed August 14, 2026.
VCBacked. (2024). Lupvindol Biosciences — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/lupvindol-biosciences
{{cite web |title=Lupvindol Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/lupvindol-biosciences |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated